Considering Your Options
Pero Wegovy, por otro lado, se enfoca en activar solo los receptores GLP-1 , lo que lleva a la supresin del apetito y una disminucin en la ingesta de caloras, pero no tiene efectos sobre la sensibilidad a la insulina, los niveles de azcar en la sangre, ni el metabolismo
The histopathologic findings can vary greatly in individual cases and in one-third of cases the pancreatic changes can be minimal, so that normal and PGBH cells can be nearly impossible to distinguish from each other
Tirzepatide, a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management, modulates hunger signals rather than eliminating them entirely
J Biol Chem 280 , 3376633774, doi: 10.1074/jbc.M504604200 (2005)